Keith Davis of Louisiana has filed a Lipitor lawsuit against Pfizer, alleging that their cholesterol-controlling drug caused him to develop type-2 diabetes.
Lipitor is a statin, a class of drugs designed to help regulate the amount of LDL or “bad” cholesterol in the blood stream. Since millions of Americans suffer from high cholesterol, the drug can help many people. However, evidence has surfaced that the drug increases some peoples’ risk of developing type-2 diabetes.
Davis began to take Lipitor in 1999. In 2011, he was diagnosed with type-2 diabetes. It was not until 2013 that he learned, from a television commercial, of the possible link between type-2 diabetes and Lipitor, leading to his Lipitor lawsuit.
Davis’ Lipitor lawsuit joins others in a multidistrict litigation (MDL) or mass tort. Mass torts are a type of group lawsuit, similar to a class action lawsuit. Both mass torts and class action lawsuits are types of group lawsuits, where a group of allegedly-wronged parties seek legal redress over similar alleged harms from the same defendants. The main difference is that class action lawsuits start out as group lawsuits, while mass torts start as individual lawsuits which are later combined into a single coordinated legal action. Because of this, individual cases within a mass tort retain a degree of autonomy.
The Lipitor lawsuit against Pfizer holds that the company was aware of the risk of diabetes when they produced and distributed the drug, and did not do enough to protect the general public. These Lipitor lawsuits further allege that drug manufactures not only did not warn consumers, but actively downplayed the risks.
To support this allegation, Lipitor lawsuits like Davis’ cite the fact that when the U.S. Food and Drug Administration demanded that Pfizer include information about the risk of diabetes, Pfizer says that Lipitor lawsuits “increases in HbAlc and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including Lipitor,” which the Lipitor lawsuit contends never plainly states that the drug can increase the risk of diabetes.
The Lipitor lawsuit is Keith John Davis v. Pfizer Incorporation, Case No. 2:14-cv-00161-JTM-DEK, in the U.S. District Court for the District of Louisiana.
In general, Lipitor lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2026 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Lipitor Class Action Lawsuit Investigation
If you’re a woman who was diagnosed with type-2 diabetes while taking Lipitor, or were diagnosed with diabetes within 90 days or less of your last dose of Lipitor, you may be eligible for compensation. See if you qualify by filling out the short form below.
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Oops! We could not locate your form.
